ELI SRL
The score of ELI shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1 % Total assets -8 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ELI's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −11,020 € | ||||
| Equity | 50,402 € | ||||
| Cash | 30,878 € | ||||
| EBITDA | −10,147 € | ||||
| Total assets | 53,448 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Oct 2026
- Year ended 31 Dec 2024filed on 28 May 2025
- Year ended 31 Dec 2023filed on 04 Jun 2024
- Year ended 31 Dec 2022filed on 30 May 2023
- Year ended 31 Dec 2021filed on 06 Jul 2022
ELI's financial analysis
- Solvency94.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ELI
ELI's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0763.330.315
- VAT number
- BE0763330315
- Peppol
- Registered · 0208:0763330315 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Feb 2021
- Registered office
- 3600 Genk
- Latest accounts
- 2025 · filed on 14 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ELI (SRL) has been based in Genk since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 11,020 € and equity of 50,402 €; its revenue is not published. Its solvency stands at 94.3%, above the median of its sector (44.2%).
Companies similar to ELI
Companies in the same business, of comparable size and area, outside its group.
- Bossiroy Pharma Retail sale of pharmaceutical products Uccle · balance sheet 65,695 €
- Caroline Vandierendonck Retail sale of pharmaceutical products Bree · balance sheet 115,934 €
- Pharmacie Marievoet Retail sale of pharmaceutical products Auderghem · balance sheet 60,288 €
- Charlie Retail sale of pharmaceutical products Retie · balance sheet 106,397 €
- OKINEO System Retail sale of pharmaceutical products Colfontaine · balance sheet 64,459 €
- MB Pharmaceutics Retail sale of pharmaceutical products Riemst · balance sheet 57,363 €
- Apego Retail sale of pharmaceutical products Geel · balance sheet 89,749 €
- TAM Pharma Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet 63,040 €
Frequently asked questions about ELI
What is the revenue of ELI?
ELI files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ELI?
In Belgium, the VAT number is the company number prefixed with BE: BE0763330315 for ELI, if the company is VAT-registered. Its company number (CBE) is 0763.330.315.
Where is the registered office of ELI?
According to the CBE register, the registered office of ELI is in 3600 Genk.
What is the equity of ELI?
At the close of the 2025 financial year, the equity of ELI amounts to 50,402 €, a solvency of 94.3% of total assets.
Who manages ELI?
The register lists 1 active mandates at ELI. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ELI
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →